Maryana Handula
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Novel dual-targeted gastrin-releasing peptide receptor and fibroblast activation protein radiopharmaceuticals for molecular imaging of heterogeneous breast tumors.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: June 16, 2026
A new series of FAP inhibitors for cancer imaging based on 8-substituted (4-quinolinoyl)-glycyl-2-cyanopyrrolidine.
Journal: Nuclear medicine and biology
Published: April 01, 2026
Assessment of quality control and effect of radiolysis on the in vivo biodistribution of [177Lu]Lu-PSMA-I&T.
Journal: EJNMMI radiopharmacy and chemistry
Published: October 03, 2025
Potentials and practical challenges of terbium-161 labeled radiopharmaceuticals.
Journal: EJNMMI radiopharmacy and chemistry
Published: June 17, 2025
A Novel Luciferase-Based Reporter Gene Technology for Simultaneous Optical and Radionuclide Imaging of Cells.
Journal: International journal of molecular sciences
Published: June 13, 2024
eTFC-01: a dual-labeled chelate-bridged tracer for SSTR2-positive tumors.
Journal: EJNMMI radiopharmacy and chemistry
Published: April 08, 2024
Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 20, 2023
[212Pb]Pb-eSOMA-01: A Promising Radioligand for Targeted Alpha Therapy of Neuroendocrine Tumors.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 09, 2023
Radiochemical and Biological Evaluation of 3p-C-NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 17, 2023
Preclinical Evaluation of a PSMA-Targeting Homodimer with an Optimized Linker for Imaging of Prostate Cancer.
Journal: Molecules (Basel, Switzerland)
Published: April 21, 2023
First preclinical evaluation of [225Ac]Ac-DOTA-JR11 and comparison with [177Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETs.
Journal: EJNMMI radiopharmacy and chemistry
Published: April 20, 2023
Pre- and Intraoperative Visualization of GRPR-Expressing Solid Tumors: Preclinical Profiling of Novel Dual-Modality Probes for Nuclear and Fluorescence Imaging.
Journal: Cancers
Published: January 27, 2023
Last Updated: 09/26/2026